We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Intuitive Surgical (ISRG) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
In its upcoming report, Intuitive Surgical, Inc. (ISRG - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $2.61 per share, reflecting an increase of 8.8% compared to the same period last year. Revenues are forecasted to be $2.88 billion, representing a year-over-year increase of 15%.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Given this perspective, it's time to examine the average forecasts of specific Intuitive Surgical metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts' assessment points toward 'Revenue- Product (Instruments and accessories and Systems)' reaching $2.38 billion. The estimate suggests a change of +12.7% year over year.
Analysts forecast 'Revenue- Services' to reach $457.34 million. The estimate indicates a change of +15.5% from the prior-year quarter.
Analysts predict that the 'Revenue- Systems' will reach $650.13 million. The estimate suggests a change of +10.1% year over year.
The collective assessment of analysts points to an estimated 'Revenue- Instruments and accessories' of $1.73 billion. The estimate indicates a year-over-year change of +13.7%.
The average prediction of analysts places 'Total System Units Placed - Total Company' at 475 . Compared to the present estimate, the company reported 427 in the same quarter last year.
The consensus estimate for 'Da Vinci Surgical System Installed Base' stands at 12,080 . The estimate is in contrast to the year-ago figure of 10,763 .
Analysts expect 'Total Number of Procedures' to come in at 902,959 . The estimate compares to the year-ago value of 797,000 .
According to the collective judgment of analysts, 'Gross Profit- Service' should come in at $303.04 million. Compared to the present estimate, the company reported $252.60 million in the same quarter last year.
It is projected by analysts that the 'Gross Profit- Product' will reach $1.57 billion. Compared to the present estimate, the company reported $1.41 billion in the same quarter last year.
The consensus among analysts is that 'Cost of revenue- Service' will reach $160.38 million.
Based on the collective assessment of analysts, 'Cost of revenue- Product' should arrive at $776.87 million.
Over the past month, shares of Intuitive Surgical have returned +9.9% versus the Zacks S&P 500 composite's +1.4% change. Currently, ISRG carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Countdown to Intuitive Surgical (ISRG) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
In its upcoming report, Intuitive Surgical, Inc. (ISRG - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $2.61 per share, reflecting an increase of 8.8% compared to the same period last year. Revenues are forecasted to be $2.88 billion, representing a year-over-year increase of 15%.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Given this perspective, it's time to examine the average forecasts of specific Intuitive Surgical metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts' assessment points toward 'Revenue- Product (Instruments and accessories and Systems)' reaching $2.38 billion. The estimate suggests a change of +12.7% year over year.
Analysts forecast 'Revenue- Services' to reach $457.34 million. The estimate indicates a change of +15.5% from the prior-year quarter.
Analysts predict that the 'Revenue- Systems' will reach $650.13 million. The estimate suggests a change of +10.1% year over year.
The collective assessment of analysts points to an estimated 'Revenue- Instruments and accessories' of $1.73 billion. The estimate indicates a year-over-year change of +13.7%.
The average prediction of analysts places 'Total System Units Placed - Total Company' at 475 . Compared to the present estimate, the company reported 427 in the same quarter last year.
The consensus estimate for 'Da Vinci Surgical System Installed Base' stands at 12,080 . The estimate is in contrast to the year-ago figure of 10,763 .
Analysts expect 'Total Number of Procedures' to come in at 902,959 . The estimate compares to the year-ago value of 797,000 .
According to the collective judgment of analysts, 'Gross Profit- Service' should come in at $303.04 million. Compared to the present estimate, the company reported $252.60 million in the same quarter last year.
It is projected by analysts that the 'Gross Profit- Product' will reach $1.57 billion. Compared to the present estimate, the company reported $1.41 billion in the same quarter last year.
The consensus among analysts is that 'Cost of revenue- Service' will reach $160.38 million.
Based on the collective assessment of analysts, 'Cost of revenue- Product' should arrive at $776.87 million.
View all Key Company Metrics for Intuitive Surgical here>>>Over the past month, shares of Intuitive Surgical have returned +9.9% versus the Zacks S&P 500 composite's +1.4% change. Currently, ISRG carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .